Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Northland Nuclear Medicine, LLC, operating as Hot Shots Nuclear Medicine, is a specialized nuclear pharmacy and radiopharmaceutical manufacturer headquartered in Bismarck, North Dakota. The company is an FDA-registered facility dedicated to the production and distribution of diagnostic imaging agents, most notably Fludeoxyglucose F18 (FDG) for Positron Emission Tomography (PET) imaging. It serves as a vital regional hub for the healthcare community in the Upper Midwest, providing time-sensitive radioactive tracers used in the diagnosis and management of cancer, cardiovascular diseases, and neurological conditions. Under the leadership of Nathan Fleck, PharmD, the facility utilizes advanced radiochemistry and cyclotron technology to meet the diagnostic needs of local hospitals and clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northland Nuclear Medicine.